Table 2.
Baseline characteristics of participants in the SwePan database
| Acute pancreatitis | Controls | |
| No (n) of participants | 95 632 | 952 783 |
| Sex, n (%) | ||
| Men | 50 079 (52.4) | 498 696 (52.3) |
| Women | 45 553 (47.6) | 454 087 (47.7) |
| Age (years) at cohort entry, n (%) | ||
| <20 | 1749 (1.8) | 17 486 (1.8) |
| 20–39 | 13 813 (14.4) | 138 116 (14.5) |
| 40–49 | 11 785 (12.3) | 117 824 (12.4) |
| 50–59 | 15 422 (16.1) | 154 129 (16.2) |
| 60–69 | 17 606 (18.4) | 175 893 (18.5) |
| 70–79 | 18 361 (19.3) | 183 361 (19.2) |
| ≥80 | 16 896 (17.7) | 165 974 (17.4) |
| Age, median (IQR) | 62 (47–75) | 62 (47–75) |
| Calendar period at cohort entry, n (%) | ||
| 1990–1994 | 11 463 (12.0) | 14 278 (12.0) |
| 1995–1999 | 13 725 (14.3) | 136 810 (14.3) |
| 2000–2004 | 14 683 (15.4) | 146 234 (15.4) |
| 2005–2009 | 15 634 (16.4) | 155 817 (16.4) |
| 2010–2014 | 19 246 (20.1) | 191 600 (20.1) |
| 2015–2019 | 20 881 (21.8) | 208 044 (21.8) |
| Country of birth, n (%) | ||
| Sweden | 80 405 (84.1) | 824 636 (86.6) |
| Outside Sweden | 15 227 (15.9) | 128 147 (13.4) |
| Charlson Comorbidity Index, n (%) | ||
| 0 | 56 646 (59.2) | 679 814 (71.4) |
| 1 | 16 929 (17.7) | 135 596 (14.2) |
| ≥2 | 22 057 (23.1) | 137 373 (14.4) |